Literature DB >> 21269564

Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells.

Baoan Chen1, Li Yin, Jian Cheng, Jiahua Ding, Chong Gao, Yunyu Sun, Gang Zhao, Jun Wang, Wen Bao, Guohua Xia, Feng Gao, Xuemei Wang.   

Abstract

In this study, we applied D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) hydrochloride as a chemical inhibitor for glucosylceramide synthase (GCS) and tetrandrine (Tet) for P-glycoprotein (P-gp) to reverse daunorubicin (DNR) resistance of human leukemia cell line K562/A02. Cytotoxicity assays showed that either PDMP or Tet enhanced cytotoxic effect of DNR on K562/A02 cells, while cotreatment of these two drugs had a more significant effect on chemosensitization. Using flow cytometric analysis, we confirmed that the enhancement effect was accompanied by elevated cellular DNR accumulation and DNR-induced apoptosis. According to reverse transcription-polymerase chain reaction and western blot, the reversal effect of that composite might owe to the significant downregulation of mdr1 and GCS gene expressions. Importantly, PDMP diminished mdr1 gene expression and Tet also downregulated GCS gene expression. Moreover, a positive correlation was observed between GCS and P-gp. Thus, our results suggest that a potential clinical application of PDMP in combination with Tet may enhance chemosensitivity in leukemia.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21269564     DOI: 10.1179/102453311X12902908411797

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  6 in total

1.  Preparation and characterization of tetrandrine-phospholipid complex loaded lipid nanocapsules as potential oral carriers.

Authors:  Yi-qing Zhao; Li-ping Wang; Chao Ma; Kun Zhao; Ying Liu; Nian-ping Feng
Journal:  Int J Nanomedicine       Date:  2013-10-31

2.  The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells.

Authors:  Ling-Yun Ye; Song Hu; Hua-E Xu; Rong-Rong Xu; Hui Kong; Xiao-Ning Zeng; Wei-Ping Xie; Hong Wang
Journal:  Cancer Cell Int       Date:  2017-03-27       Impact factor: 5.722

3.  Tetrandrine combined with gemcitabine and Cisplatin for patients with advanced non-small cell lung cancer improve efficacy.

Authors:  Wenchao Liu; Ju Zhang; Cheng Ying; Qianrong Wang; Chen Yan; Yang Jingyue; Yu Zhaocai; Xue Yan; Shi Heng-Jun; Jiang Lin
Journal:  Int J Biomed Sci       Date:  2012-03

4.  Targeted multidrug-resistance reversal in tumor based on PEG-PLL-PLGA polymer nano drug delivery system.

Authors:  Liting Guo; Haijun Zhang; Fei Wang; Ping Liu; Yonglu Wang; Guohua Xia; Ran Liu; Xueming Li; Haixiang Yin; Hulin Jiang; Baoan Chen
Journal:  Int J Nanomedicine       Date:  2015-07-16

Review 5.  Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy.

Authors:  Ting Liu; Xin Liu; Wenhua Li
Journal:  Oncotarget       Date:  2016-06-28

6.  Tetrandrine partially reverses multidrug resistance of human laryngeal cancer cells.

Authors:  Yachun Li; Dongjie Li; Ping Wang; Wei Zhu; Wanzhong Yin
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.